Literature DB >> 34463670

Increasing Hepatitis C Screening in a Federally Qualified Health Center: A Quality Improvement Initiative.

Melissa D Klein, Bryna J Harrington, Joan East, Jennifer Cunningham, Nicole Ifill, Jan Lee Santos.   

Abstract

ABSTRACT: Hepatitis C virus (HCV) is a chronic infection that can lead to severe liver damage if left untreated. With increased availability and affordability of curative treatments, screening for HCV has become an important first step in reducing morbidity and mortality. At a rural federally qualified health center in North Carolina, two quality improvement initiatives-an electronic health record (EHR) prompt and educational flyers-were implemented to improve HCV screening rates. We compared the proportion of eligible patients born from 1945 to 1965 who received HCV screening before, during, and after the initiatives. HCV screening rates were highest during the two initiatives (30% and 39%, respectively). Screening rates fell in the 6-month period after the initiatives' conclusion (12%) but remained higher than at baseline (6%). Although HCV screening can increase with simple interventions, more durable solutions are needed to maintain screening coverage.
Copyright © 2020 National Association for Healthcare Quality.

Entities:  

Mesh:

Year:  2021        PMID: 34463670      PMCID: PMC8415006          DOI: 10.1097/JHQ.0000000000000278

Source DB:  PubMed          Journal:  J Healthc Qual        ISSN: 1062-2551            Impact factor:   1.095


  19 in total

Review 1.  Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.

Authors:  Megan G Hofmeister; Elizabeth M Rosenthal; Laurie K Barker; Eli S Rosenberg; Meredith A Barranco; Eric W Hall; Brian R Edlin; Jonathan Mermin; John W Ward; A Blythe Ryerson
Journal:  Hepatology       Date:  2018-11-06       Impact factor: 17.425

2.  Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers.

Authors:  Monica A Konerman; Mary Thomson; Kristen Gray; Meghan Moore; Hetal Choxi; Elizabeth Seif; Anna S F Lok
Journal:  Hepatology       Date:  2017-09-14       Impact factor: 17.425

3.  Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014.

Authors:  Catelyn Coyle; Helena Kwakwa; Kendra Viner
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

4.  Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.

Authors:  Maxine M Denniston; R Monina Klevens; Geraldine M McQuillan; Ruth B Jiles
Journal:  Hepatology       Date:  2012-04-10       Impact factor: 17.425

5.  Evaluation of a Multifaceted Intervention to Reduce Health Disparities in Hepatitis C Screening: A Pre-Post Analysis.

Authors:  Mamta K Jain; Nicole E Rich; Chul Ahn; Barbara J Turner; Joanne M Sanders; Brian Adamson; Lisa Quirk; Patrice Perryman; Noel O Santini; Amit G Singal
Journal:  Hepatology       Date:  2019-05-31       Impact factor: 17.425

6.  The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.

Authors:  David B Rein; John S Wittenborn; Bryce D Smith; Danielle K Liffmann; John W Ward
Journal:  Clin Infect Dis       Date:  2015-03-16       Impact factor: 9.079

7.  Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013.

Authors:  Kathleen N Ly; Elizabeth M Hughes; Ruth B Jiles; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2016-03-01       Impact factor: 9.079

8.  Hepatitis C screening trends in a large integrated health system.

Authors:  Benjamin P Linas; Haihong Hu; Devra M Barter; Michael Horberg
Journal:  Am J Med       Date:  2014-01-28       Impact factor: 5.928

9.  Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system.

Authors:  Alexander G Geboy; Whitney L Nichols; Stephen J Fernandez; Sameer Desale; Peter Basch; Dawn A Fishbein
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

10.  Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.

Authors:  Harinder S Chahal; Elliot A Marseille; Jeffrey A Tice; Steve D Pearson; Daniel A Ollendorf; Rena K Fox; James G Kahn
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 44.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.